Get a glimpse into our company and investor data—powered by the PitchBook Platform
GrantLATEST DEAL TYPE
$29.2KLATEST DEAL AMOUNT
Developer of medicinal drugs designed to offer treatment for ophthalmic diseases. The company's drugs focuses on ocular surface diseases by providing advanced medicinal products, enabling patients to recover faster from dry eye syndrome.